2021 Pediatric Grand Rounds | Recent Advances in Cancer Immunotherapy - Kids Too?

Duarte, CA US
April 1, 2021

The field of cancer immunotherapy is advancing fast and requires frequent updates; application of the principles of cancer immunotherapy from adult to pediatric malignancies is also valuable. Immunotherapy is not curing all malignancies currently and many guiding principles of immunotherapy using various modalities have been evaluated in adult malignancies. Pediatric malignancies are less common and, therefore, a longer time is required before sufficient number of patients have been treated to achieve statistically significant results. Updates regarding the current state of immunotherapy for adult malignancies can inform clinical trial design and patient management for pediatric malignancies.

Target Audience

Pediatric Hematology/Oncology Physicians, Advance Practice Practitioners, staff and research team.

Learning Objectives

  • Demonstrate an understanding of basic concepts of cancer immunotherapy.
  • Identify the settings in which unique approaches can be applied, e.g. intratumoral therapy.
  • Assess the pros and cons of various combination therapies.
  • Describe the gaps in pediatric malignancy immunotherapy.

Additional Information

AttachmentSize
PDF icon AB 1195 Biblio158.47 KB
Activity summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
    City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
    City of Hope designates this 2021 Pediatric Grand Rounds | Recent Advances in Cancer Immunotherapy - Kids Too? for a maximum of 1.00 AMA PRA Category 1 Credit™ requirements. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.00 Attendance
Activity opens: 
04/01/2021
Activity expires: 
04/02/2021
Event starts: 
04/01/2021 - 12:00pm PDT
Event ends: 
04/01/2021 - 1:00pm PDT
Add to calendar: 
City of Hope
1500 E Duarte Rd
Duarte, CA 91010
United States

Virtual Meeting- Zoom

Kim Margolin, MD, FASCO   Professor Emeritus, City of Hope; Adjunct Professor, USC Medical Oncology

Dr. Margolin has indicated that she is a Consultant for Checkmate Pharmaceuticals; ImaginAb; Iovance; OncoSec; Pfizer; Tentarix; and Werewolf Therapeutics.

ACCREDITATION STATEMENT: City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CREDIT DESIGNATION: City of Hope designates this live webinar for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

The following credit type(s) are being offered for this course:

•  AMA PRA Category 1™  1.0

The following may apply AMA PRA Category 1 Credit™ for license renewal:

Registered Nurses: Nurses may report up to 1.0 credit hours toward the continuing education requirements for license renewal by their state Board of Registered Nurses (BRN). AMA PRA Category 1 Credit™ may be noted on the license renewal application in lieu of a BRN provider number.

Physician Assistants: The National Commission on Certification of Physicians Assistants states that AMA PRA Category 1 Credit™ accredited courses are acceptable for CME requirements for recertification.

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
    City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
    City of Hope designates this 2021 Pediatric Grand Rounds | Recent Advances in Cancer Immunotherapy - Kids Too? for a maximum of 1.00 AMA PRA Category 1 Credit™ requirements. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.00 Attendance
Please login or register to take this activity.